241 related articles for article (PubMed ID: 9334893)
1. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study.
Scahill L; Riddle MA; King RA; Hardin MT; Rasmusson A; Makuch RW; Leckman JF
J Child Adolesc Psychopharmacol; 1997; 7(2):75-85. PubMed ID: 9334893
[TBL] [Abstract][Full Text] [Related]
2. Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder.
Husted DS; Shapira NA; Murphy TK; Mann GD; Ward HE; Goodman WK
J Psychiatr Res; 2007; 41(3-4):332-7. PubMed ID: 16860338
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience.
Riddle MA; Hardin MT; King R; Scahill L; Woolston JL
J Am Acad Child Adolesc Psychiatry; 1990 Jan; 29(1):45-8. PubMed ID: 2295577
[TBL] [Abstract][Full Text] [Related]
4. A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome.
Kurlan R; Como PG; Deeley C; McDermott M; McDermott MP
Clin Neuropharmacol; 1993 Apr; 16(2):167-72. PubMed ID: 8477412
[TBL] [Abstract][Full Text] [Related]
5. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome.
Bloch MH; Peterson BS; Scahill L; Otka J; Katsovich L; Zhang H; Leckman JF
Arch Pediatr Adolesc Med; 2006 Jan; 160(1):65-9. PubMed ID: 16389213
[TBL] [Abstract][Full Text] [Related]
6. Childhood movement disorders and obsessive compulsive disorder.
Swedo SE; Leonard HL
J Clin Psychiatry; 1994 Mar; 55 Suppl():32-7. PubMed ID: 7915713
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.
Geller DA; Hoog SL; Heiligenstein JH; Ricardi RK; Tamura R; Kluszynski S; Jacobson JG;
J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):773-9. PubMed ID: 11437015
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
[TBL] [Abstract][Full Text] [Related]
10. An open-label trial of fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette's syndrome.
Como PG; Kurlan R
Neurology; 1991 Jun; 41(6):872-4. PubMed ID: 2046933
[TBL] [Abstract][Full Text] [Related]
11. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children.
Leonard HL; Lenane MC; Swedo SE; Rettew DC; Gershon ES; Rapoport JL
Am J Psychiatry; 1992 Sep; 149(9):1244-51. PubMed ID: 1503140
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
[TBL] [Abstract][Full Text] [Related]
13. Psychopharmacotherapy of Obsessive-Compulsive Symptoms within the Framework of Tourette Syndrome.
Rothenberger A; Roessner V
Curr Neuropharmacol; 2019; 17(8):703-709. PubMed ID: 30152283
[TBL] [Abstract][Full Text] [Related]
14. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
[TBL] [Abstract][Full Text] [Related]
15. Clinical features distinguishing patients with Tourette's syndrome and obsessive-compulsive disorder from patients with obsessive-compulsive disorder without tics.
Petter T; Richter MA; Sandor P
J Clin Psychiatry; 1998 Sep; 59(9):456-9. PubMed ID: 9771815
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC
J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).
Alaghband-Rad J; Hakimshooshtary M
Eur Child Adolesc Psychiatry; 2009 Mar; 18(3):131-5. PubMed ID: 19190958
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome.
Peterson BS; Zhang H; Anderson GM; Leckman JF
J Clin Psychopharmacol; 1998 Aug; 18(4):324-31. PubMed ID: 9690699
[TBL] [Abstract][Full Text] [Related]
19. An open trial and discontinuation study of fluoxetine in children and adolescents with obsessive-compulsive disorder.
Semerci ZB; Unal F
Turk J Pediatr; 2001; 43(4):323-8. PubMed ID: 11765163
[TBL] [Abstract][Full Text] [Related]
20. Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder.
Delgado PL; Goodman WK; Price LH; Heninger GR; Charney DS
Br J Psychiatry; 1990 Nov; 157():762-5. PubMed ID: 2126219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]